Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alphavis-T
- Development stage
- Unknown
- Lead developer
- Grevis Pharma
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
Alphavis-T is a fixed-dose combination ophthalmic solution developed and marketed by Grevis Pharma for the management of intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. The formulation contains brimonidine tartrate (0.2%), a selective alpha-2 adrenergic receptor agonist, and timolol maleate (0.5%), a non-selective beta-adrenergic receptor blocker. These components work through complementary mechanisms: timolol reduces the formation of aqueous humor, while brimonidine both decreases aqueous humor production and enhances uveoscleral outflow. This dual action effectively lowers IOP in patients who require more than one medication to achieve target pressure levels. It is administered topically as eye drops twice daily.
- Brand names
- Alphavis-T
- Other names
- brimonidine tartrate + timolol maleate eye dropsbrimonidine + timolol
02
Targets
ADRA2A (α2A)ADRB1 (β1)ADRB2 (β2)
Beyond the preview
Go deeper on Alphavis-T.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alphavis-T.